A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice

Oncology Research

Volumn 17, Issue 11-12, 2009, Pages 581-591

  Otsuka, Shinsaku ^a   Hanibuchi, Masaki ^a   Ikuta, Kenji ^a   Yano, Seiji ^b   Goto, Hisatsugu ^a   Ogino, Hirokazu ^a   Yamada, Tadaaki ^b   Kakiuchi, Soji ^a   Nishioka, Yasuhiko ^a   Takahashi, Takashi ^c   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone metastasis model; Lung adenocarcinoma; Osteoblastic bone metastasis; Osteolytic bone metastasis

Indexed keywords

BETA ACTIN; BEVACIZUMAB; ENDOTHELIN 1; INTERLEUKIN 6; PARATHYROID HORMONE RELATED PROTEIN; VASCULOTROPIN; ZOLEDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; IMIDAZOLE DERIVATIVE; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; LIVER METASTASIS; LUNG CANCER; LUNG METASTASIS; MALE; METASTASIS INHIBITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; OSTEOLYSIS; OSTEOPHYTE; PRIORITY JOURNAL; SCID MOUSE; ADENOCARCINOMA; ANIMAL; BONE TUMOR; DISEASE MODEL; HUMAN; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; LUNG TUMOR; METASTASIS; MOUSE MUTANT; OSTEOBLAST; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; BONE NEOPLASMS; CELL LINE, TUMOR; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; HUMANS; IMIDAZOLES; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED ICR; MICE, SCID; OSTEOBLASTS; OSTEOLYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70350505889     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504009789745511     Document Type: Article

References (34)

1. Quint, L. E.; Francis, I. R.; Wahl, R. L.; Gross, B. H. Imaging of lung cancer. In: Pass, H. I.; Mitchell, J. B.; Johnson, D. H.; Turrisi, A. T., eds. Lung cancer: Principles and practice. Philadelphia: Lippincott-Raven; 1996: 437-470.
2. Ginsberg, R. J.; Vokes, E. E.; Rosenzweig, K. Non-small cell lung cancer. In: DeVita, Jr., V. T.; Hellman, S.; Rosenberg, S. A., eds. Cancer principles and practice of cncology. Philadelphia: Lippincott-Raven; 2001:925-981.
3. Sullivan, F. J. Palliative radiotherapy for lung cancer. In: Pass, H. I.; Mitchell, J. B.; Johnson, D. H.; Turrisi, A. T., eds. Lung cancer: Principles and practice. Philadelphia: Lippincott-Raven; 1996:775-789.
4. Iguchi, H.; Onuma, E.; Sato, K.; Ogata, E. Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen. Int. J. Cancer 94:24-27; 2001.
5. Miki, T.; Yano, S.; Hanibuchi, M.; Sone, S. Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice. Oncol. Res. 12:209-217; 2000.
6. Sone, S.; Yano, S. Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone. Cancer Metastasis Rev. 26:685-689; 2007.
7. Miki, T.; Yano, S.; Hanibuchi, M.; Kanematsu, T.; Muguruma, H.; Sone, S. Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice. Int. J. Cancer 108:511-515; 2004.
8. Yano, S.; Zhang, H.; Hanibuchi, M.; Miki, T.; Goto, H.; Uehara, H.; Sone, S. Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastases of small cell lung cancer cells in severe combined immunodeficient mice. Clin. Cancer Res. 9:5380-5385; 2003.
9. Yano, S.; Muguruma, H.; Matsumori, Y.; Goto, H.; Nakataki, E.; Edakuni, N.; Tomimoto, H.; Kakiuchi, S.; Yamamoto, A.; Uehara, H.; Ryan, A.; Sone, S. Antitumor vascular strategy for controlling experimental metastatic spread of human small cell lung cancer cells with ZD6474 in natural killer cell-depleted severe combined immunodeficiency mice. Clin. Cancer Res. 11:8789-8798; 2005.
10. Hall, C. L.; Keller, E. T. The role of Wnts in bone metastases. Cancer Metastasis Rev. 25:551-558; 2006.
11. Kiura, K.; Watarai, S.; Shibayama, T.; Ohnoshi, T.; Kimura, I.; Yasuda, T. Inhibitory effects of cholera toxin on in vitro growth of human lung cancer cell lines. Anti-cancer Drug Des. 8:417-428; 1993.
12. Tanaka, T.; Kitamura, F.; Nagasaka, Y.; Kuida, K.; Suwa, H.; Miyasaka, M. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor β chain monoclonal antibody in mice. J. Exp. Med. 178: 1103-1107; 1993.
13. Yano, S.; Nishioka, Y.; Izumi, K.; Tsuruo, T.; Tanaka, T.; Miyasaka, M.; Sone, S. Novel metastasis model of human lung cancer in SCID mice depleted of NK cells. Int. J. Cancer 67:211-217; 1996.
14. Kakiuchi, S.; Daigo, Y.; Tsunoda, T.; Yano, S.; Sone, S.; Nakamura, Y. Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice. Mol. Cancer Res. 1:485-499; 2003.
15. Guise, T. A.; Mohammad, K. S.; Clines, G.; Stebbins, E. G.; Wong, D. H.; Higgins, L. S.; Vessella, R.; Corey, E.; Padalecki, S.; Suva, L.; Chirgwin, J. M. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin. Cancer Res. 12:6213s-6216s; 2006.
16. Kitagawa, Y.; Dai, J.; Zhang, J.; Keller, J. M.; Nor, J.; Yao, Z.; Keller, E. T. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Cancer Res. 65:10921-10929; 2005.
17. Wang, C. Y.; Chang, Y. W. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: A new biological and clinical parameter for prostatic carcinoma. Oncol. Res. 9:419-431; 1997.
18. Wu, T. T.; Sikes, R. A.; Cui, Q.; Thalmann, G. N.; Kao, C.; Murphy, C. F.; Yang, H.; Zhau, H. E.; Balian, G.; Chung, L. W. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int. J. Cancer 77:887-894; 1998.
19. Uehara, H.; Kim, S. J.; Karashima, T.; Shepherd, D. L.; Fan, D.; Tsan, R.; Killion, J. J.; Logothetis, C.; Mathew, P.; Fidler, I. J. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases. J. Natl. Cancer Inst. 95:458-470; 2003.
20. Feeley, B. T.; Liu, N. Q.; Conduah, A. H.; Krenek, L.; Roth, K.; Dougall, W. C.; Huard, J.; Dubinett, S.; Lieberman, J. R. Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration. J. Bone Miner. Res. 21:1571-1580; 2006.
21. Roudier, M. P.; Morrissey, C.; True, L. D.; Higano, C. S.; Vessella, R. L.; Ott, S. M. Histopathological assessment of prostate cancer bone osteoblastic metastases. J. Urol. 180:1154-1160; 2008.
22. Schwaninger, R.; Rentsch, C. A.; Wetterwald, A.; van der Horst, G.; van Bezooijen, R. L.; van der Pluijm, G.; Lowik, C. W.; Ackermann, K.; Pyerin, W.; Hamdy, F. C.; Thalmann, G. N.; Cecchini, M. G. Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases. Am. J. Pathol. 170:160-175; 2007.
23. Dougall, W. C.; Chaisson, M. The RANK/RANKL/OPG triad in cancer-induced bone diseases. Cancer Metastasis Rev. 25:541-549; 2006.
24. Yano, S.; Shinohara, H.; Herbst, R. S.; Kuniyasu, H.; Bucana, C. D.; Ellis, L. M.; Fidler, I. J. Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells. Am. J. Pathol. 157:1893-1903; 2000.
25. Senger, D. R.; Galli, S. J.; Dvorak, A. M.; Perruzzi, C. A.; Harvey, V. S.; Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985; 1983.
26. Hiltunen, M. O.; Ruuskanen, M.; Huuskonen, J.; Mähönen, A. J.; Ahonen, M.; Rutanen, J.; Kosma, V. M.; Mahonen, A.; Kröger, H.; Ylä-Herttualab, S. Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo. FASEB J. 17:1147-1149; 2003.
27. Boldrini, L.; Gisfredi, S.; Ursino, S.; Faviana, P.; Lucchi, M.; Melfi, F.; Mussi, A.; Basolo, F.; Fontanini, G. Expression of endothelin-1 is related to poor prognosis in non-small cell lung carcinoma. Eur. J. Cancer 41:2828-2835; 2005.
28. Arun, C.; DeCatris, M.; Hemingway, D. M.; London, N. J.; O'Byrne, K. J. Endothelin-1 is a novel prognostic factor in non-small cell lung cancer. Int. J. Biol. Markers 19:262-267; 2004.
29. Sasaki, A.; Boyce, B. F.; Story, B.; Wright, K. R.; Chapman, M.; Boyce, R.; Mundy, G. R.; Yoneda, T. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res. 55: 3551-3557; 1995.
30. Kostenuik, P. J.; Orr, F. W.; Suyama, K. L.; Singh, G. Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats. Cancer Res. 53:5452-5457; 1993.
31. Corey, E.; Brown, L. G.; Quinn, J. E.; Poot, M.; Roudier, M. P.; Higano, C. S.; Vessella, R. L. Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer. Clin. Cancer Res. 9:295-306; 2003.
32. Thudi, N. K.; Martin, C. K.; Nadella, M. V.; Fernandez, S. A.; Werbeck, J. L.; Pinzone, J. J.; Rosol, T. J. Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions. Prostate 68:1116-1125; 2008.
33. Yano, S.; Nokihara, H.; Hanibuchi, M.; Parajuli, P.; Shinohara, T.; Kawano, T.; Sone, S. Model of malignant pleural effusion of human lung adenocarcinoma in SCID mice. Oncol. Res. 9:573-579; 1997.
34. Morikawa, K.; Walker, S. M.; Jessup, J. M.; Fidler, I. J. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res. 48:1943-1948; 1988.